Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Virtual pelvic program aims to ease pain and boost sexual health in women

NCT ID NCT06999395

Symptom relief Sponsor: Queen's University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether a 3-month online pelvic health program can reduce pain and improve sexual wellbeing in adult women with provoked vestibulodynia, a condition causing chronic genital pain. The program includes pain education, relaxation exercises, and pelvic floor exercises. Researchers will compare women who start the program right away to those who wait, measuring pain, sexual function, and satisfaction.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
virtual online pelvic health program
What this could lead to
If it works, this could provide an accessible, self-guided treatment option for women with chronic genital pain, reducing pain and improving sexual function.
What could go wrong
This is a relatively small trial (250 people) testing a behavioral intervention, not a drug. Results may vary, and the program may not work for everyone. It is also limited to English-speaking women in North America.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 250 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2025

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Self-reported physician diagnosis of provoked vestibulodynia (PVD) * PVD duration of at least 3 months * PVD pain intensity rating of at least 3 on a scale from 0 (no pain) to 10 (extreme pain) * Resides in North America (Canada or the United States) * Fluent in English Exclusion Criteria: * Less than 18 years old * Pregnancy or suspected pregnancy * Breastfeeding * Up to one year postpartum * Physical or mental health conditions that significantly interfere with activities of daily living

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Provoked localized vulvodynia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Pain Vulvar Vestibulitis vulvodynia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Provoked localized vulvodynia Provoked vestibulodynia Vestibulodynia Vulvar vestibulitis Vulvodynia (chronic vulvar pain)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Sexual Health Research Laboratory

    RECRUITING

    Kingston, Ontario, K7L 3N6, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.